Skip to main content
Learning for life
Fully Funded Options available for Rural GPs [Click here for more information]
Browse
Search
A - C
D - F
G - L
M - O
P - R
S - Z
Conferences
CPD
Start Free Trial
Sign in
Start Free Trial
Sign In
Live stream preview
Watch this video and more on armchairmedical.tv
Watch this video and more on armchairmedical.tv
Start your free trial
Learn more
Already subscribed?
Sign in
The proportion of patients who reach the BMD surrogate threshold effect on romosozumab a post hoc analysis of the randomised FRAME and ARCH phase 3 trials Prof Jeffrey Hassall
ANZ Bone & Mineral Society 2022
• 9m 51s
Share with friends
Facebook
Twitter
Email
Share on Facebook
Share on Twitter
Share via Email
Watch anywhere, anytime
iPhone
Android
Up Next in
ANZ Bone & Mineral Society 2022
15:17
Patients on dialysis are at lower ris...
Patients on dialysis are at lower ris...
29:25
Minghao Zheng Orthopaedic Innovation ...
Minghao Zheng Orthopaedic Innovation ...
31:19
Emerging approaches to investigate mu...
Emerging approaches to investigate mu...
